|
Apr 3
|
XOMA Corporation Announces Closing of Tender Offer
|
|
Mar 19
|
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
|
|
Mar 1
|
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories
|
|
Feb 28
|
Kinnate Biopharma Inc. (KNTE) Upgraded to Buy: What Does It Mean for the Stock?
|
|
Dec 6
|
13 Hot Penny Stocks To Buy According to Hedge Funds
|
|
Aug 8
|
Kinnate Biopharma Inc. Reports Second Quarter 2023 Financial Results and Recent Corporate Updates
|